Axogen vs Orthopediatrics
Axogen and Orthopediatrics are similar in size: $225m and $236m of revenue in their latest fiscal years. Axogen grew faster (20.2% against 15.4%). Axogen kept more of each dollar of sales as profit: a net margin of -7.0% against -16.8%.
| Latest fiscal year | AxogenAXGN, 2025 | OrthopediatricsKIDS, 2025 |
|---|---|---|
| Revenue | $225m | $236m |
| Revenue growth | 20.2% | 15.4% |
| Net income | −$15.7m | −$39.6m |
| Operating margin | -3.5% | — |
| Net margin | -7.0% | -16.8% |
| Return on equity | -13.5% | -11.3% |
| Free cash flow | −$2.9m | −$16.0m |
| Cash | $35.5m | $19.6m |
| Total debt | $48.4m | $106m |
| Debt to equity | 37.6% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 622 | 602 |
| Market value | $2.95bn | $750m |
| Price vs our value range | — | — |
| Moat score | 31 (Weak) | 35 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |